The significance of the specific Nusselt number on a variety of factors. by Siva Sankari (2827295)

Subjects:

The significance of the specific Nusselt number on a variety of factor. by Siva Sankari (2827295)

Subjects:

Relation between training-related changes in unipedal and bipedal stance. by Cristina Dolciotti (16317330)

Subjects:

Cardiovascular-kidney-metabolic syndrome-related Age-Adjusted Mortality Rates per 1,000,000 in Adults in the Metropolitan and Non-metropolitan areas in the United States, 1999 to 2... by Aman Goyal (19231397)

Subjects:

Multi-organ differential gene expression changes statistically significant at hypertension onset. by Eden Hornung (20148295)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells. by Hong Tian (169626)

Path analysis diagram illustrating the associations between alexithymia, social support, anticipated stigma and patient satisfaction, with their respective correlation coefficients... by Keya Bibikar (22386306)

GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. by Ziyue Liu (381532)

Changes in average income reduction rate of households over time across different income groups. by Na Chen (153323)

Changes in total spillage during the second stage (in-epidemic). by Cuicui Liu (1496260)

Original full-length gel image related to Fig 5. Full, non-adjusted gel image corresponding to the Western blot data shown in Fig 5. Molecular weight markers are indicated in kilod... by Jin-Hwa Kim (101817)

Subjects:

Neutrophil Superoxide anion production, Heat map for gene expression from neutrophils of CGD patients, and PCA plot for genome-wide gene expression. by Daniel R. Ambruso (12042605)

“…Heat map</b> showing changes for all significant genes between off IFN-γ and 10-12 hours after the 1st and 4th dose (50 µg/m²) of the cytokine given on a routine schedule noted in Methods. …”

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, the respective treatment counts for anti-VEGF, STTA, MA-PC, PPV, and total treatments (mean ± standard deviation) in the year before surgery were 3.0 ± 1.4, 0.1 ± 0.3, 0.8 ± 1.0, 0.1 ± 0.3, and 4.0 ± 2.1, respectively. These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”

Sudden change from skewed distributions. by Ariel Burman (20329776)

Time and spatial sensitivity to process changes. by Ariel Burman (20329776)

Cortisol and prolactin concentration in non-pregnant women. by Francois Kiemde (5369657)

Subjects:

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-t... by Emir Matpan (21655811)